Evidence & Innovation
In Case You Missed It!
- Katherine H. Capps, Co-Founder, Executive Director, GTMRx
- Julie Ceno-England, MD, Chief Medical Officer, OneOme
- Steven W. Chen, PharmD, FASHP, FCSHP, FNAP, Associate Professor, Associate Dean for Clinical Affairs and Heeres Chair in Community Pharmacy, USC School of Pharmacy
- Michael Hochman, MD, MPH, Chief Executive Officer, Scan’s Homeless Medical Group; Inaugural Director, USC Gehr Center for Health Systems Science & Innovation
- Mitchell A. Kaminski, MD, MBA, Program Director, Population Health, Jefferson College of Population Health
- Early stage CMM practice (1-2 years)
- Mid-level stage CMM practice (10+)
- Fully mature CMM practice (20+)
Celebrating 3 Years of Impact: GTMRx Institute Turns 3!
- A personalized, patient-centered, systematic and coordinated approach to medication use will vastly improve outcomes and reduce overall health care costs.
- We must align systems of care to integrate comprehensive medication management, engaging patients to ensure that they are willing and able to take those medications that are indicated, effective, and safe, to optimize their outcomes.
- We need immediate delivery system, payment, and policy transformation to streamline clinical trials and reduce costs of bringing drugs to market while enabling successful, broad-scale adoption of integrated, comprehensive medication management (CMM) services.
- Appropriate diagnosis and access to advanced diagnostics with companion/complementary and pharmacogenetics (PGx) testing is essential to target correct therapy.
- Success requires team-based, patient-centered care models that recognize appropriately skilled clinical pharmacists as medication experts who work in collaborative practice with physicians and other providers.